In addition, ArthroCare’s sports medicine line grew 6 percent from fourth quarter 2012 to $3.8 million in fourth quarter 2013, including a $1.6 million domestic increase in product sales and a $1.3 million increase in international sales.
For more information on sales, revenues, expenses and growth for ArthroCare’s fourth quarter 2013, view the news release.
More Articles on Devices & Implants:
35 Spine & Orthopedic Devices Receive FDA 501(k) Clearance in January
OMNI Surgical Navigation System Reaches 3k Knee Surgeries
RTI Surgical Reports $60.5M in 4Q Revenue
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
